TEVA-CEPHALEXIN CAPSULE

Χώρα: Καναδάς

Γλώσσα: Αγγλικά

Πηγή: Health Canada

Αγόρασέ το τώρα

Αρχείο Π.Χ.Π. Αρχείο Π.Χ.Π. (SPC)
12-08-2020

Δραστική ουσία:

CEPHALEXIN (CEPHALEXIN MONOHYDRATE)

Διαθέσιμο από:

TEVA CANADA LIMITED

Φαρμακολογική κατηγορία (ATC):

J01DB01

INN (Διεθνής Όνομα):

CEFALEXIN

Δοσολογία:

500MG

Φαρμακοτεχνική μορφή:

CAPSULE

Σύνθεση:

CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 500MG

Οδός χορήγησης:

ORAL

Μονάδες σε πακέτο:

50/100/250/500/1000

Τρόπος διάθεσης:

Prescription

Θεραπευτική περιοχή:

FIRST GENERATION CEPHALOSPORINS

Περίληψη προϊόντος:

Active ingredient group (AIG) number: 0105911003; AHFS:

Καθεστώς αδειοδότησης:

APPROVED

Ημερομηνία της άδειας:

2014-07-11

Αρχείο Π.Χ.Π.

                                1
PRODUCT MONOGRAPH
PR
TEVA-CEPHALEXIN
250 mg and 500 mg
Cephalexin Capsules, USP
PR
TEVA-CEPHALEXIN
250 mg and 500 mg
Cephalexin Tablets, USP
PR
TEVA-CEPHALEXIN 125
125 mg/5 mL Cephalexin For Oral Suspension, USP
PR
TEVA-CEPHALEXIN 250
250 mg/5 mL Cephalexin For Oral Suspension, USP
ANTIBIOTIC
Teva Canada Limited
Date of Revision:
30 Novopharm Court
August 12, 2020
Toronto, Ontario
Canada M1B 2K9
www.tevacanada.com
Control # 237728
2
PRODUCT MONOGRAPH
PR
TEVA-CEPHALEXIN
250 mg and 500 mg
Cephalexin Capsules, USP
PR
TEVA-CEPHALEXIN
250 mg and 500 mg
Cephalexin Tablets, USP
PR
TEVA-CEPHALEXIN 125
125 mg/5 mL Cephalexin For Oral Suspension, USP
PR
TEVA-CEPHALEXIN 250
250 mg/5 mL Cephalexin For Oral Suspension, USP
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION
TEVA-CEPHALEXIN is bactericidal against many gram-positive and
gram-negative organisms.
_In vitro_
tests demonstrate that the cephalosporins are bactericidal through
their inhibition of cell-
wall synthesis
(15)
.
INDICATIONS
TEVA-CEPHALEXIN may be indicated for the treatment of bacterial
infections of the
respiratory tract
(1,12)(l3,l4)
, including otitis media
(1,2)
, genitourinary tract
(3)
, bone and joints
(4,5)
,
skin and soft tissue
(6,7)
, when the infection is caused by susceptible organisms. Culture and
susceptibility studies should be performed.
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of TEVA-
CEPHALEXIN and other antibacterial drugs, TEVA-CEPHALEXIN should be
used only to treat
infections that are proven or strongly suspected to be caused by
susceptible bacteria. When
culture and susceptibility information are available, they should be
considered in selecting or
modifying antibacterial therapy. In the absence of such data, local
epidemiology and
susceptibility patterns may contribute to the empiric selection of
therapy.
3
CONTRAINDICATIONS
TEVA-CEPHALEXIN (cephalexin) is contraindicated in patients with known
allergy to the
cephalosporin group of antibiotics.
WARNINGS
Before therapy with TEVA-CEPHALEXIN
(c
                                
                                Διαβάστε το πλήρες έγγραφο
                                
                            

Έγγραφα σε άλλες γλώσσες

Αρχείο Π.Χ.Π. Αρχείο Π.Χ.Π. Γαλλικά 12-08-2020

Αναζήτηση ειδοποιήσεων που σχετίζονται με αυτό το προϊόν

Προβολή ιστορικού εγγράφων